Dollars for Docs

How Industry Dollars Reach Your Doctors

COPAXONE
drug

COPAXONE

Reduces the frequency of flare-ups (relapses) in patients who have relapsing-remitting multiple sclerosis (RMMS).
Cash
$25.3M

payments related to this drug

Doctor
6,612

doctors receiving payments

Company
1

company making payments related to this drug

Drug
0%

of payments for this drug were also associated with another product

Companies Making Payments Related to this Drug

Aggregate totals are shown, including payments to doctors and teaching hospitals. To purchase bulk data, please visit the ProPublica Data Store.

Company Payment
TEVA PHARMACEUTICALS USA, INC. $25.3M

Top Doctors Receiving Payments Related to this Drug

Totals listed account for all payments from August 2013 to December 2016.

Doctor Location Money Paid
BANDARI
DANIEL BANDARI

NEWPORT BEACH, CA

$551K
KASPER
LLOYD KASPER

LEBANON, NH

$448K
ZAMVIL
SCOTT ZAMVIL

SAN FRANCISCO, CA

$390K
LEIST
THOMAS LEIST

PHILADELPHIA, PA

$326K
KHAN
OMAR KHAN

DETROIT, MI

$308K
PARRY
GARETH PARRY

MINNEAPOLIS, MN

$291K
Bowling
Allen Bowling

ENGLEWOOD, CO

$281K
ITKIN
ARTHUR ITKIN

PALOS HEIGHTS, IL

$274K
MURRAY
RONALD MURRAY

BILLINGS, MT

$272K
Khatri
Bhupendra Khatri

MILWAUKEE, WI

$251K

Note: We have made some effort to normalize the data and eliminate duplicates, but data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].